Clinical Trial Update: CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material [NA]

View source ↗

Summary

CAPTURE-2 trial status update indicates the study investigating controlled arterial protection to remove embolic material is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Aortic Valve Stenosis

Snippet

Sponsor: EmStop Inc | Conditions: Aortic Valve Stenosis, Aortic Stenosis | NA | Status: NOT_YET_RECRUITING